Medicare delays full obesity-drug program rollout after insurers push back

Without big Medicare insurers, the future of program to cover popular obesity drugs had been in question.

340B drug discounts are drifting from patients to profit, and reform is now on the table

The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking ...
Hosted on MSN

CMS delays Medicare obesity drug program to 2027 amid insurer pushback

The Centers for Medicare & Medicaid Services (CMS) has postponed its BALANCE program, intended to integrate obesity drugs into Medicare Part D, to January 2027 after failing to secure sufficient ...

WhiteSands Alcohol & Drug Rehab Publishes New Website Resource Highlighting Patient Recovery Outcomes Through Outpatient Treatment Programs

WhiteSands Alcohol & Drug Rehab has published a new resource on its website examining a patient-reported recovery experience through structured outpatient care. The article documents a patient’s ...